Beneath the surface: Novel insights into Amivantamab-induced acneiform rash.

Nikolaou, Vasiliki; Gerochristou, Maria; Sgontzou, Themis; Silaidi, Christina; Stratigos, Alexander

Nikolaou, Vasiliki; Gerochristou, Maria; Sgontzou, Themis; Silaidi, Christina; Stratigos, Alexander.

Affiliation

Nikolaou V; 1st Department of Dermatology, Cutaneous Toxicities Clinic, Onco-Dermaatology Department, "Andreas Syggros" Hospital for skin diseases, National & Kapodestrian University of Athens, Medical School, Greece. Electronic address: drviknik@yahoo.com.
Gerochristou M; 1st Department of Dermatology, Cutaneous Toxicities Clinic, Onco-Dermaatology Department, "Andreas Syggros" Hospital for skin diseases, National & Kapodestrian University of Athens, Medical School, Greece.
Sgontzou T; 1st Department of Dermatology, Cutaneous Toxicities Clinic, Onco-Dermaatology Department, "Andreas Syggros" Hospital for skin diseases, National & Kapodestrian University of Athens, Medical School, Greece.
Silaidi C; 1st Department of Dermatology, Cutaneous Toxicities Clinic, Onco-Dermaatology Department, "Andreas Syggros" Hospital for skin diseases, National & Kapodestrian University of Athens, Medical School, Greece.
Stratigos A; 1st Department of Dermatology, Cutaneous Toxicities Clinic, Onco-Dermaatology Department, "Andreas Syggros" Hospital for skin diseases, National & Kapodestrian University of Athens, Medical School, Greece.

Eur J Cancer ; 208: 114198, 2024 Jun 27.

Article de En | MEDLINE | ID: mdl-38971041

Mots clés

Acneiform rash; Amivantamab; Skin toxicity; Ulcerative scalp lesions

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Eur J Cancer Année: 2024 Type de document: Article